Journal
Blood Advances
Publication Date
1-24-2023
Volume
7
Issue
2
First Page
236
Last Page
245
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2022007496
Rights and Permissions
Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, Spies NC, Ruzinova MB, Wang T, Abro B, Kreisel F, Parikh BA, Duncavage EJ, Frater JL, Lee YS, Hassan A, King JA, Kohnen DR, Fiala MA, Welch JS, Uy GL, Vij K, Vij R, Griffith M, Griffith OL, Wartman LD. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Adv. 2023 Jan 24;7(2):236-245. doi: 10.1182/bloodadvances.2022007496. © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Barnell, Erica K; Skidmore, Zachary L; Newcomer, Kenneth F; Chavez, Monique; Campbell, Katie M; Cotto, Kelsy C; Spies, Nicholas C; Ruzinova, Marianna B; Wang, Tianjiao; Abro, Brooj; Parikh, Bijal A; Duncavage, Eric J; Frater, John L; Lee, Yi-Shan; Hassan, Anjum; King, Justin A; Kohnen, Daniel R; Fiala, Mark A; Welch, John S; Uy, Geoffrey L; Vij, Kiran; Vij, Ravi; Griffith, Malachi; Griffith, Obi L; Wartman, Lukas D; and et al., "Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma." Blood Advances. 7, 2. 236 - 245. (2023).
https://digitalcommons.wustl.edu/oa_4/1378
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
